Research Article
Oxidative Stress: Dual Pathway Induction in Cardiorenal Syndrome Type 1 Pathogenesis
Table 3
Oxidative stress and IL-6 levels in AHF, CRS Type 1 patients, and CTR.
| | | AHF | CRS Type 1 | CTR | value |
| | MPO, pg/mL | 505.6 (421.7–547.8) | 746.9 (665.2–940.0) | 10.1 (6.0–19.3) | <0.01 | | NO, µM | 205.6 (95.0–277.5) | 507.3 (404.7–557.3) | 9.5 (6.1–12.2) | <0.01 | | Cu/ZnSOD, pg/mL | 184.5 (160.5–192.0) | 274.5 (191.8–326.8) | 58.9 (51.7–70.9) | <0.01 | | EPA, U/L | 274.5 (191.8–326.8) | 2978.4 (2071.8–4069.9) | 2.0 (0.9–3.9) | <0.01 | | IL-6, pg/mL | 22.19 (16.6–24.6) | 90.68 (59.9–105.3) | 5.9 (3.4–7.6) | <0.01 |
|
|
Values denote medians (IQR).
|
